Pancreatic cancer is one of the deadliest forms of cancer, largely because it’s so difficult to catch early. By the time it’s ...

Discovery Analysis Demonstrates Transformative Sensitivity of 95% with Specificity of 98% for the Detection of Pancreatic Cancer in Blood ...

Mainz Biomed has the exclusive rights to develop a test for early pancreatic cancer detection using Liquid Biosciences' biomarkers.

Furthermore, existing biomarkers, such as CA19-9, are not reliable on their own to detect early-stage pancreatic cancer. Goel, Xu, and colleagues explored the potential of an exosome-based liquid ...

A new blood test could diagnose pancreatic cancer ... As with most types of cancer, once the tumor has spread, it becomes much harder to successfully treat. “Liquid biopsy” tests which use ...

"Unlike traditional imaging, which requires specific equipment and expertise, liquid biopsy could become a widely accessible ...

Liquid biopsies are poised to redefine cancer care by integrating the principles of care convergence and aligning diagnostics and treatment across disciplines. Care convergence isn’t just a ...

Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the ... endoscopic ultrasound and other liquid biopsy tests that require ...

A new blood test could help doctors detect pancreatic cancer earlier ... unlike an endoscopic ultrasound and other liquid biopsy tests that require large volumes of blood, thus allowing our ...